MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
about
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1.
P2860
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
@en
type
label
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
@en
prefLabel
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
@en
P2860
P1476
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities
@en
P2093
J R Fraser Cummings
Simon R Whiteoak
P2860
P304
P356
10.1097/MIB.0000000000000288
P577
2015-05-01T00:00:00Z